Literature DB >> 21478738

Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis.

John Muscedere1, Oleksa Rewa, Kyle McKechnie, Xuran Jiang, Denny Laporta, Daren K Heyland.   

Abstract

BACKGROUND AND
PURPOSE: Aspiration of secretions containing bacterial pathogens into the lower respiratory tract is the main cause of ventilator-associated pneumonia. Endotracheal tubes with subglottic secretion drainage can potentially reduce this and, therefore, the incidence of ventilator-associated pneumonia. New evidence on subglottic secretion drainage as a preventive measure for ventilator-associated pneumonia has been recently published and to consider the evidence in totality, we conducted an updated systematic review and meta-analysis.
DESIGN: We searched computerized databases, reference lists, and personal files. We included randomized clinical trials of mechanically ventilated patients comparing standard endotracheal tubes to those with subglottic secretion drainage and reporting on the occurrence of ventilator-associated pneumonia. Studies were meta-analyzed for the primary outcome of ventilator-associated pneumonia and secondary clinical outcomes.
MEASUREMENTS AND MAIN RESULTS: We identified 13 randomized clinical trials that met the inclusion criteria with a total of 2442 randomized patients. Of the 13 studies, 12 reported a reduction in ventilator-associated pneumonia rates in the subglottic secretion drainage arm; in meta-analysis, the overall risk ratio for ventilator-associated pneumonia was 0.55 (95% confidence interval, 0.46-0.66; p < .00001) with no heterogeneity (I = 0%). The use of subglottic secretion drainage was associated with reduced intensive care unit length of stay (-1.52 days; 95% confidence interval, -2.94 to -0.11; p = .03); decreased duration of mechanically ventilated (-1.08 days; 95% confidence interval, -2.04 to -0.12; p = .03), and increased time to first episode of ventilator-associated pneumonia (2.66 days; 95% confidence interval, 1.06-4.26; p = .001). There was no effect on adverse events or on hospital or intensive care unit mortality.
CONCLUSIONS: In those at risk for ventilator-associated pneumonia, the use of endotracheal tubes with subglottic secretion drainage is effective for the prevention of ventilator-associated pneumonia and may be associated with reduced duration of mechanical ventilation and intensive care unit length of stay.

Entities:  

Mesh:

Year:  2011        PMID: 21478738     DOI: 10.1097/CCM.0b013e318218a4d9

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  63 in total

1.  Randomized Pilot Trial of Two Modified Endotracheal Tubes To Prevent Ventilator-associated Pneumonia.

Authors:  Steven Deem; David Yanez; Laura Sissons-Ross; Jo Ann Elrod Broeckel; Stephen Daniel; Miriam Treggiari
Journal:  Ann Am Thorac Soc       Date:  2016-01

Review 2.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

Review 3.  [Enteral nutrition therapy in critical care : Current knowledge, controversies, and practical implementation].

Authors:  A Hohn; D Stolecki; S Schröder
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-06-20       Impact factor: 0.840

4.  A 2015 Update on Ventilator-Associated Pneumonia: New Insights on Its Prevention, Diagnosis, and Treatment.

Authors:  Braden Waters; John Muscedere
Journal:  Curr Infect Dis Rep       Date:  2015-08       Impact factor: 3.725

Review 5.  Update on management of tracheostomy.

Authors:  H Lewith; V Athanassoglou
Journal:  BJA Educ       Date:  2019-09-26

Review 6.  Novel preventive strategies for ventilator-associated pneumonia.

Authors:  Andrea Coppadoro; Edward Bittner; Lorenzo Berra
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

Review 7.  Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia.

Authors:  Juan F Fernandez; Stephanie M Levine; Marcos I Restrepo
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

8.  Ventilator-associated conditions versus ventilator-associated pneumonia: different by design.

Authors:  Michael Klompas
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

Review 9.  [Ventilator-associated pneumonia (VAP) : A risk already at the time of anesthetic induction].

Authors:  L Vetter; C Konrad; G Schüpfer; M Rossi
Journal:  Anaesthesist       Date:  2017-02       Impact factor: 1.041

10.  The prevalence of suspected ventilator-associated pneumonia in Scottish intensive care units.

Authors:  Robert Hart; Scott McNeill; Sarah Maclean; Jamie Hornsby; Sarah Ramsay
Journal:  J Intensive Care Soc       Date:  2019-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.